RhumbLine Advisers’s Akcea Therapeutics, Inc. Common Stock AKCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-22,512
| Closed | -$408K | – | 3072 |
|
|
2020
Q3 | $408K | Sell |
22,512
-3,160
| -12% | -$57.3K | ﹤0.01% | 2382 |
|
|
2020
Q2 | $352K | Buy |
25,672
+8,521
| +50% | +$117K | ﹤0.01% | 2496 |
|
|
2020
Q1 | $245K | Buy |
17,151
+127
| +0.7% | +$1.81K | ﹤0.01% | 2492 |
|
|
2019
Q4 | $288K | Buy |
17,024
+184
| +1% | +$3.11K | ﹤0.01% | 2617 |
|
|
2019
Q3 | $259K | Sell |
16,840
-125
| -0.7% | -$1.92K | ﹤0.01% | 2642 |
|
|
2019
Q2 | $398K | Sell |
16,965
-194
| -1% | -$4.55K | ﹤0.01% | 2459 |
|
|
2019
Q1 | $486K | Buy |
17,159
+409
| +2% | +$11.6K | ﹤0.01% | 2340 |
|
|
2018
Q4 | $505K | Buy |
16,750
+5,208
| +45% | +$157K | ﹤0.01% | 2294 |
|
|
2018
Q3 | $404K | Sell |
11,542
-704
| -6% | -$24.6K | ﹤0.01% | 2366 |
|
|
2018
Q2 | $290K | Sell |
12,246
-818
| -6% | -$19.4K | ﹤0.01% | 2552 |
|
|
2018
Q1 | $335K | Buy |
13,064
+1,695
| +15% | +$43.5K | ﹤0.01% | 2385 |
|
|
2017
Q4 | $197K | Sell |
11,369
-1,393
| -11% | -$24.1K | ﹤0.01% | 2637 |
|
|
2017
Q3 | $353K | Buy |
+12,762
| New | +$353K | ﹤0.01% | 2493 |
|